- Investopedia•8 days ago
Prima is running trials to treat breast cancer and skin cancer using combinations of its drug IMP321.
- Marketwired•13 days ago
Prima BioMed Ltd , is pleased to announce that its French subsidiary, Immutep S.A.S., has received EUR 618,307 in payment of a research tax credit from the French state under the Crédit d'Impôt Recherche ...
PBMD : Summary for Prima BioMed Ltd - American Dep - Yahoo Finance
Prima Biomed Ltd. (PBMD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Ask||7.40 x 100|
|Day's Range||2.41 - 2.53|
|52 Week Range||0.51 - 3.26|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|